Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study.

BACKGROUND

The gut microbiota is increasingly recognized as a key modulator in obesity management, influencing host energy balance, lipid metabolism, and inflammatory pathways. With obesity prevalence continuing to rise globally, dietary interventions that promote beneficial microbial shifts are essential for enhancing weight loss outcomes and long-term health.

OBJECTIVE

This study investigated the effects of the multicomponent Weight Loss Maintenance 3 Phases Program (WLM3P), which integrates caloric restriction, a high-protein low-carbohydrate diet, time-restricted eating (10h TRE), dietary supplementation (prebiotics and phytochemicals), and digital app-based support on gut microbiota composition compared to a standard low-carbohydrate diet (LCD) in adults with obesity. The analysis focused exclusively on the 6-month weight loss period corresponding to Phases 1 and 2 of the WLM3P intervention.

METHODS

In this sub-analysis of a randomized controlled trial (ClinicalTrials.gov Identifier: NCT04192357), 58 adults with obesity (BMI 30.0-39.9 kg/m) were randomized to the WLM3P ( = 29) or LCD ( = 29) groups. Stool samples were collected at baseline and 6 months for 16S rRNA sequencing. Alpha and beta diversity were assessed, and genus-level differential abundance was determined using EdgeR and LEfSe. Associations between microbial taxa and clinical outcomes were evaluated using regression models.

RESULTS

After 6-month, the WLM3P group showed a significant increase in alpha diversity ( = 0.03) and a significant change in beta diversity ( < 0.01), while no significant changes were observed in the LCD group. Differential abundance analysis revealed specific microbial signatures in WLM3P participants, including increased levels of . Notably, higher abundance was associated with greater reductions in fat mass (kg, %) and visceral adiposity (cm) in the WLM3P group compared to LCD ( < 0.01).

CONCLUSIONS

These findings suggest a potential microbiota-mediated mechanism in weight loss, where may enhance fat reduction effectiveness in the context of the WLM3P intervention.